Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients
Study Details
Study Description
Brief Summary
Further knowledge regarding sequelae in severe COVID-19 patients who have required ICU admission for invasive mechanical ventilation is still needed. Available evidence suggests ongoing respiratory impairment and impact in quality of life.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
PURPOSE: To evaluate post-ICU clinical outcomes in severe COVID-19 ICU survivors.
DESIGN: A prospective observational study conducted in public hospital in Madrid, Spain.
METHODS:
Participants: patients diagnosed with severe COVID-19 who have survived ICU admission for invasive mechanical ventilation and have been discharged from hospital.
Intervention: Patients will be invited to attend follow-up visits at the hospital for assessments 3 months and 6 months after ICU discharge.
Outcome measures: Tests of respiratory muscles function will include ultrasonography of the diaphragm muscle to measure diaphragm thickness (DT), diaphragm thickening ratio (TR) and diaphragm excursion (DE); respiratory muscle strength measurement to obtain Maximal Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP) and Maximal Sniff Nasal Inspiratory Pressure (SNIP); functional exercise capacity will be assessed with the Six Minutes Walk Test (6MWT); dyspnea and health-related quality of life will be evaluated with the Modified Medical Research Council Scale (mMRC Scale) and the Saint George's Respiratory Questionnaire (SGRQ). Data on participants' demographics and clinical data will also be collected.
Statistical Analysis: Descriptive statistics will be used to summarise data. Spearman's correlation coefficients will be used to explore associations between variables.
CONCLUSIONS AND SIGNIFICANCE OF THE RESEARCH: Understanding post-ICU clinical outcomes in patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up strategies that improve quality of care and outcomes
Study Design
Outcome Measures
Primary Outcome Measures
- Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20) [< 3 months after ICU discharge]
It is the greater pressure which may be generated during maximal inspiration by the inspiratory muscles.
- Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20) [within 6 months after ICU discharge]
It is the greater pressure which may be generated during maximal inspiration by the inspiratory muscles.
Secondary Outcome Measures
- Diaphragm Thickening Ratio during deep breathing (centimetres) [within 3 months after ICU discharge]
B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio during deep breathing. Diaphragm Thickening Ratio = Diaphragm Thickness at Functional Residual Capacity/ Diaphragm thickness at Total Lung Capacity.
- Diaphragm Thickening Ratio during deep breathing (centimetres) [within 6 months after ICU discharge]
B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio during deep breathing. Diaphragm Thickening Ratio = Diaphragm Thickness at Functional Residual Capacity/ Diaphragm thickness at Total Lung Capacity.
- Diaphragm Thickening Ratio during quiet breathing (centimetres) [within 3 months after ICU discharge]
B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio at Tidal Volume. Diaphragm Thickening Ratio = Diaphragm Thickness at the end of a quiet expiration/ Diaphragm thickness at the end of a quiet inspiration.
- Diaphragm Thickening Ratio during quiet breathing (centimetres) [within 6 months after ICU discharge]
B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio at Tidal Volume. Diaphragm Thickening Ratio = Diaphragm Thickness at the end of a quiet expiration/ Diaphragm thickness at the end of a quiet inspiration.
- Diaphragm Excursion during deep breathing (centimetres) [within 3 months after ICU discharge]
M-mode Diaphragm Ultrasound imaging will be performed to measure diaphragm excursion during deep breathing defined as the displacement (centimetres) of the diaphragm between Functional Residual Capacity and Total Lung Capacity
- Diaphragm Excursion during deep breathing (centimetres) [within 6 months after ICU discharge]
M-mode Diaphragm Ultrasound imaging will be performed to measure diaphragm excursion during deep breathing defined as the displacement (centimetres) of the diaphragm between Functional Residual Capacity and Total Lung Capacity.
- Maximal Expiratory Pressure (MEP) (cmH20) [within 3 months after ICU discharge]
It is the greater pressure which may be generated during maximal expiration by the inspiratory muscles.
- Maximal Expiratory Pressure (MEP) (cmH20) [within 6 months after ICU discharge]
It is the greater pressure which may be generated during maximal expiration by the inspiratory muscles.
- Modified Medical Research Council (mMRC) Dyspnea score [within 3 months following ICU discharge]
Dyspnea will be measured with the mMRC Dyspnea scale (range: 0-4, higher values indicating higher level of dyspnea)
- Modified Medical Research Council (mMRC) Dyspnea score [within 6 months following ICU discharge]
Dyspnea will be measured with the mMRC Dyspnea scale (range: 0-4, higher values indicating higher level of dyspnea)
- 6-Minutes Walk Test (6MWT) (metres) [within 3 months following ICU discharge]
The 6MWT will be used to measure exercise capacity
- 6-Minutes Walk Test (6MWT) (metres) [within 6 months following ICU discharge]
The 6MWT will be used to measure exercise capacity
- Saint George's Respiratory Questionnaire (SGRQ) score [within 3 months following ICU dischargemonths following ICU discharge]
The SGRQ is used to measure health-related quality of life (range: 0-100, higher scores represent higher impairment in quality of life)
- Saint George's Respiratory Questionnaire (SGRQ) score [within 6 months following ICU dischargemonths following ICU discharge]
The SGRQ is used to measure health-related quality of life (range: 0-100, higher scores represent higher impairment in quality of life)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
⋧18 years old,
-
subjects diagnosed with COVID-19 confirmed by positive SARS-CoV-2 PCR testing who require admission to ICU for invasive mechanical ventilation
-
invasive ventilation > 24 hours.
Exclusion Criteria:
-
pre-existing cognitive impairment,
-
communication/language barrier
-
any concurrent physical or mental health condition/ impairment that prevents subjects from taking part in evaluations or providing informed consent
-
loss of independent walking ability (with or without walking aids) prior to hospitalisation defined by a score of ≤2 on the mobility item of the modified Barthel Index,
-
pregnancy,
-
any injuries/surgery that requires medical bed rest.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | ICU. Ramón y Cajal University Hospital | Madrid | Spain | 28034 |
Sponsors and Collaborators
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Investigators
- Principal Investigator: Luís López-González, BSc,MSc, Fundación Ramón y Cajal
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 419/20